share_log
Breakings ·  Jun 17 18:45
Takeda Pharmaceutical Co Ltd: Skyline Study in Dravet Syndrome Narrowly Missed Its Primary Endpoint
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment